Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FXGVN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,249
Award facts
- Contract value 100% obligated
- $6,249.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,249.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on October 20, 2025, with an ultimate completion date of November 10, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply procurement for Department of Defense healthcare operations.
DMS Pharmaceutical Group has held its PPV-G GEN V prime vendor contract since November 13, 2025, with a ceiling value of $499,999,999 and a term extending through December 31, 2036, consisting of a 30-month base period and three 30-month option periods. As one of multiple regional prime vendor contractors under this strategic sourcing vehicle, the company supplies a comprehensive portfolio of pharmaceutical products—including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables—to military healthcare facilities worldwide. The contractor's recent delivery orders demonstrate its established performance and capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FXGVN?
SPE2DB26FXGVN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FXGVN worth?
The government has obligated $6,249 on SPE2DB26FXGVN.
Is contract SPE2DB26FXGVN an order under another contract?
Yes. SPE2DB26FXGVN is a delivery order under SPE2DB25D9306, an indefinite delivery contract.
Was contract SPE2DB26FXGVN competed?
The extent of competition for SPE2DB26FXGVN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award